4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
September 3, 2010 12:34 pm US/Eastern
Search
Dynamic quotes   
On
 | Off
  • Technical Analysis
  • Market Quotes
  • Market News
  • Market Screeners and Tools

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI-AVENTIS   SAN   FR0000120578

SANOFI-AVENTIS (SAN)

  
Real time Streaming quotes -
Real-time Quote. Real-time Tradegate - 09/03 12:34:22 pm
46.811 EUR   +0.94%
09/01SANOFI-AVENTIS: Largest Atrial Fibrillation Registry Reveals Poor AF Control an..
08/30SANOFI-AVENTIS: Information concerning the total number of voting rights and sh..
08/30SANOFI-AVENTIS: Teriflunomide Significantly Reduced Annualized Relapse Rate and..
SummaryQuotesChart AnalysisNewsCalendarCompanyFundamentalsConsensus
 NewsRSS News
Latest news on SANOFI-AVENTIS
09/01Largest Atrial Fibrillation Registry Reveals Poor AF Control and High Rates of C..
08/30Information concerning the total number of voting rights and shares, provided pu..
08/30Teriflunomide Significantly Reduced Annualized Relapse Rate and was well Tolerat..
08/30Announces Non-Binding Offer to Acquire Genzyme
08/30Multaq® First-line Option in New 2010 ESC Guidelines for the Management of Atria..
08/26Comments on Injunctive Relief Hearing Regarding Lovenox®
08/02Availability on line of the Group's half-year financial report for 2010
07/29Video Q&A: CEO Chris Viehbacher comments on earnings for Q2 2010
07/27And Merck appoint Raul Kohan as CEO for the new Animal Health joint venture
07/26Expresses concern over the approval of another version of enoxaparin sodium in t..
07/23Information concerning the total number of voting rights and shares, provided pu..
07/19Jevtana® (cabazitaxel) Injection Now Available in the U.S.
07/01Information concerning the total number of voting rights and shares, provided pu..
07/01And JDRF Form Partnership to Improve Therapies, Work Toward Cure for Type 1 Diab..
07/01Rifapentine is granted Orphan Drug Status by European Commission for Treatment o..
06/30To acquire TargeGen Inc., a US biopharmaceutical company
06/28Improved Outcomes for Patients Treated with Lantus® and Apidra® Regimen Compared..
06/28Less Glycemic Variability, Better Patient Reported Outcomes with Lantus® and Api..
06/25And Metabolex enter into an Exclusive Worldwide Licensing Agreement for a Novel ..
06/22And Regulus Therapeutics Form Major Strategic Alliance on microRNA Therapeutics
06/08Sanofi Pasteur Partners With Vivalis For The Discovery of Human Monoclonal Antib..
06/07Teriflunomide in adjunct to interferon beta significantly improved outcomes of M..
06/04And US Biopharmaceutical Company Ascenta Therapeutics Sign License Agreement in ..
05/31The Charité University in Berlin and sanofi-aventis Sign an Innovative Research ..
05/28And Generics Leader Nichi-Iko to Establish New Joint Venture for Generics in Jap..
05/27Updated Phase 3 Survival Results with Cabazitaxel in Patients with Advanced Horm..
05/26Establishes Strategic Alliance with MIT's Center for Biomedical Innovation
05/25Wins the 2010 Global Business Coalition Core Competence Award for its Innovative..
05/19To Reinforce its Consumer Health Care Platform in Poland
05/18Information concerning the total number of voting rights and shares, provided pu..
05/18Combined General Shareholder Meeting of May 17, 2010
05/17Announces the Creation of the ?Sanofi Espoir? Corporate Foundation
05/12Initiates 10,000 Patient Study with Multaq® in Permanent Atrial Fibrillation
05/03And Glenmark Pharmaceuticals Sign License Agreementon Novel Agents to treat Chro..
04/30Change in sanofi-aventis Executive Committee
04/30Board of Directors - Combined General Meeting of May 17, 2010
04/27Information concerning the total number of voting rights and shares, provided pu..
04/23Announces Court Decision Resolving Eloxatin® U.S. Patent Litigation
04/21Sanofi-aventis' Combined General Shareholder Meeting to be held May 17, 2010
04/15Once Daily Lixisenatide (AVE 0010) Given as Monotherapy Successfully Meets Phase..
04/12Sanofi Pasteur Partners with U.S. Naval Medical Research Center to Advance Devel..
04/12Board of Directors of sanofi-aventis
04/08Successfully completes a tap on its October 2014 bond for 500 million Euros
04/08Successfully completes a tap on its October 2014 bond for 500 million Euros
04/08And CureDM Sign Exclusive Worldwide License Agreement on Novel Regenerative Comp..
04/06Makes updated settlement announcement regarding Eloxatin® U.S. Patent litigation
04/06Amends Its Alliance Agreement with Warner Chilcott Regarding Actonel® in the Uni..
04/01Announces Settlement of Eloxatin® U.S. Patent litigation
03/31Information concerning the total number of voting rights and shares, provided pu..
03/31Invests ?150 million in France and continues its Change towards Biotechnologies
1  2  3  4  5  6Next
Chart SANOFI-AVENTIS
Short term
Mid-term
Long term
Graphique historique des cours de bourse de SANOFI-AVENTIS
Full-screen chart
Income Statement Evolution
SANOFI-AVENTIS : Income Statement Evolution
More Fundamentals
EPS Reviews
SANOFI-AVENTIS : EPS Reviews
More Estimates Reviews
Price share SANOFI-AVENTIS (FRANCE), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /